Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Neoplasms 3Recurrence 1Pancreatic Neoplasms 1Oligometastatic Lung Adenocarcinoma 1Neoplasm Metastasis 1NSCLC 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioma 1Gastrointestinal Neoplasms 1EGFR Mutation Positive Non-small Cell Lung Cancer 1Carcinoma 1Breast Neoplasms 1

Interventions

Radiotherapy 2Practice Guidelines as Topic 2Heavy Ion Radiotherapy 2seocalcitol 1pembrolizumab 1Yoga 1X-Rays 1Tomography, Optical Coherence 1Surveys and Questionnaires 1Standard of Care 1Sentinel Lymph Node Biopsy 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiofrequency Ablation 1Pluvicto 1Platinum Compounds 1Pemetrexed 1Nurses 1Nivolumab 1Nimorazole 1NF protocol 1Magnetic Resonance Spectroscopy 1Lasers, Solid-State 1Lasers, Gas 1Itraconazole 1Inulin 1Interviews as Topic 1Hearing 1Fluorodeoxyglucose F18 1Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma × Erlotinib Hydrochloride × Clear all
NCT00125372 2019-01-08

Study of Tarceva and Targretin in Stage I-II Lung Cancer

Dartmouth-Hitchcock Medical Center

Phase NA Completed
12 enrolled 10 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡